190 related articles for article (PubMed ID: 23865878)
1. Evaluation of the use of serum C-reactive protein concentration to predict outcome in puppies infected with canine parvovirus.
McClure V; van Schoor M; Thompson PN; Kjelgaard-Hansen M; Goddard A
J Am Vet Med Assoc; 2013 Aug; 243(3):361-6. PubMed ID: 23865878
[TBL] [Abstract][Full Text] [Related]
2. Serum cortisol and thyroxine concentrations as predictors of death in critically ill puppies with parvoviral diarrhea.
Schoeman JP; Goddard A; Herrtage ME
J Am Vet Med Assoc; 2007 Nov; 231(10):1534-9. PubMed ID: 18020996
[TBL] [Abstract][Full Text] [Related]
3. Determination of serum organic acids in puppies with naturally acquired parvoviral enteritis.
Nappert G; Dunphy E; Ruben D; Mann FA
Can J Vet Res; 2002 Jan; 66(1):15-8. PubMed ID: 11858643
[TBL] [Abstract][Full Text] [Related]
4. Effect of parvoviral enteritis on plasma citrulline concentration in dogs.
Dossin O; Rupassara SI; Weng HY; Williams DA; Garlick PJ; Schoeman JP
J Vet Intern Med; 2011; 25(2):215-21. PubMed ID: 21281355
[TBL] [Abstract][Full Text] [Related]
5. Factors affecting the occurrence, duration of hospitalization and final outcome in canine parvovirus infection.
Iris Kalli ; Leontides LS; Mylonakis ME; Adamama-Moraitou K; Rallis T; Koutinas AF
Res Vet Sci; 2010 Oct; 89(2):174-8. PubMed ID: 20303134
[TBL] [Abstract][Full Text] [Related]
6. Recombinant human granulocyte colony-stimulating factor for treatment of puppies with neutropenia secondary to canine parvovirus infection.
Rewerts JM; McCaw DL; Cohn LA; Wagner-Mann C; Harrington D
J Am Vet Med Assoc; 1998 Oct; 213(7):991-2. PubMed ID: 9776994
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of serum acute-phase proteins in dogs with parvoviral enteritis.
Kocaturk M; Martinez S; Eralp O; Tvarijonaviciute A; Ceron J; Yilmaz Z
J Small Anim Pract; 2010 Sep; 51(9):478-83. PubMed ID: 20630018
[TBL] [Abstract][Full Text] [Related]
8. Recombinant bactericidal/permeability-increasing protein (rBPI21) for treatment of parvovirus enteritis: a randomized, double-blinded, placebo-controlled trial.
Otto CM; Jackson CB; Rogell EJ; Prior RB; Ammons WS
J Vet Intern Med; 2001; 15(4):355-60. PubMed ID: 11467593
[TBL] [Abstract][Full Text] [Related]
9. Clinical, hematological, and biochemical findings in puppies with coronavirus and parvovirus enteritis.
Castro TX; Cubel Garcia Rde C; Gonçalves LP; Costa EM; Marcello GC; Labarthe NV; Mendes-de-Almeida F
Can Vet J; 2013 Sep; 54(9):885-8. PubMed ID: 24155496
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of increased canine pancreas-specific lipase concentrations in young dogs with parvovirus enteritis.
Kalli IV; Adamama-Moraitou KK; Patsika MN; Pardali D; Steiner JM; Suchodolski JS; Menexes G; Brellou GD; Rallis TS
Vet Clin Pathol; 2017 Mar; 46(1):111-119. PubMed ID: 28125171
[TBL] [Abstract][Full Text] [Related]
11. Effect of systemic inflammatory response syndrome on thrombocytogram, acute phase proteins, electrolytes, acid-base indices and cytokine expression in naturally canine parvovirus infected dogs.
Paul BR; De UK; Sarkar VK; Gandhar JS; Patra MK; Agrawal RK; Singh MK; Soni S; Eregowda CG
Vet Immunol Immunopathol; 2023 May; 259():110598. PubMed ID: 37119726
[TBL] [Abstract][Full Text] [Related]
12. Prognostic usefulness of blood leukocyte changes in canine parvoviral enteritis.
Goddard A; Leisewitz AL; Christopher MM; Duncan NM; Becker PJ
J Vet Intern Med; 2008; 22(2):309-16. PubMed ID: 18371025
[TBL] [Abstract][Full Text] [Related]
13. Ionized and total magnesium concentrations in blood from dogs with naturally acquired parvoviral enteritis.
Mann FA; Boon GD; Wagner-Mann CC; Ruben DS; Harrington DP
J Am Vet Med Assoc; 1998 May; 212(9):1398-401. PubMed ID: 9589125
[TBL] [Abstract][Full Text] [Related]
14. Assessment of certain biomarkers for predicting survival in response to treatment in dogs naturally infected with canine parvovirus.
Eregowda CG; De UK; Singh M; Prasad H; Akhilesh ; Sarma K; Roychoudhury P; Rajesh JB; Patra MK; Behera SK
Microb Pathog; 2020 Dec; 149():104485. PubMed ID: 32926999
[TBL] [Abstract][Full Text] [Related]
15. Characterisation of lipid profiles in dogs with parvoviral enteritis.
Yilmaz Z; Senturk S
J Small Anim Pract; 2007 Nov; 48(11):643-50. PubMed ID: 17617157
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Potential of Thrombocyte Indices, Acute Phase Proteins, Electrolytes and Acid-Base Markers in Canine Parvovirus Infected Dogs With Systemic Inflammatory Response Syndrome.
Paul BR; Kumar De U; Sarkar VK; Gandhar JS; Patra MK; Singh MK; Soni S; Eregowda CG
Top Companion Anim Med; 2023; 56-57():100803. PubMed ID: 37598980
[TBL] [Abstract][Full Text] [Related]
17. Serum cobalamin concentrations in dogs infected with canine parvoviral enteritis.
Engelbrecht M; Botha WJ; Pazzi P; McClure V; Hooijberg E
J Am Vet Med Assoc; 2022 Feb; 260(7):1-8. PubMed ID: 35113794
[TBL] [Abstract][Full Text] [Related]
18. Prognostic indicators at presentation for canine parvoviral enteritis: 322 cases (2001-2018).
Chalifoux NV; Parker SE; Cosford KL
J Vet Emerg Crit Care (San Antonio); 2021 May; 31(3):402-413. PubMed ID: 33792158
[TBL] [Abstract][Full Text] [Related]
19. Tei index (myocardial performance index) and cardiac biomarkers in dogs with parvoviral enteritis.
Kocaturk M; Martinez S; Eralp O; Tvarijonaviciute A; Ceron J; Yilmaz Z
Res Vet Sci; 2012 Feb; 92(1):24-9. PubMed ID: 21074228
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of an outpatient protocol in the treatment of canine parvoviral enteritis.
Venn EC; Preisner K; Boscan PL; Twedt DC; Sullivan LA
J Vet Emerg Crit Care (San Antonio); 2017 Jan; 27(1):52-65. PubMed ID: 27918639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
